A client exploring sequencing methodologies and technologies — with a focus on automation and future trends — needed lab leadership, not lab adjacency: directors at molecular clinical diagnostic labs running NGS in-house or outsourcing it.
We fielded 90 surveys of 35 minutes across the US, UK, France, Italy, Germany, Spain, Japan, Korea, China, Singapore, and Australia, covering in-house NGS runs and automation processes, an adaptive choice-based conjoint on NGS automation, and forecasts for genomics and sequencing.
Recruitment to completion: three weeks, across eleven markets, with the conjoint build done in-house.
Hard audiences, hard method, one accountable team. Talk to our team.
